Artivion, Inc. Enters Material Definitive Agreement
Ticker: AORT · Form: 8-K · Filed: Sep 15, 2025 · CIK: 784199
| Field | Detail |
|---|---|
| Company | Artivion, Inc. (AORT) |
| Form Type | 8-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $150.0 million, $30,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: debt, financing, material-agreement
TL;DR
ARTIVION just signed a big deal, creating a new financial obligation. Watch this space.
AI Summary
On September 12, 2025, Artivion, Inc. entered into a material definitive agreement, specifically a credit agreement, which creates a direct financial obligation for the company. This agreement is a significant event for Artivion, Inc., as detailed in their 8-K filing.
Why It Matters
This filing indicates Artivion, Inc. has entered into a new financial obligation, which could impact its debt structure and financial flexibility.
Risk Assessment
Risk Level: medium — Entering into new financial obligations can introduce financial risks related to debt servicing and covenants.
Key Players & Entities
- Artivion, Inc. (company) — Registrant
- September 12, 2025 (date) — Date of earliest event reported
- 1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144 (address) — Principal executive offices
FAQ
What type of material definitive agreement did Artivion, Inc. enter into?
Artivion, Inc. entered into a credit agreement, as indicated by the filing.
What is the significance of this agreement for Artivion, Inc.?
The agreement creates a direct financial obligation for the registrant.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported was on September 12, 2025.
What is Artivion, Inc.'s principal business address?
Artivion, Inc.'s principal business address is 1655 Roberts Boulevard, N.W., Kennesaw, Georgia 30144.
What is the SEC Act and File Number associated with this filing?
The SEC Act is 1934 Act and the SEC File Number is 001-13165.
Filing Stats: 992 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2025-09-15 07:58:55
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value AORT NYSE Indicate by check
- $150.0 million — volving Credit Facility and (iii) a new $150.0 million secured delayed draw term loan facility
- $30,000,000 — the balance of outstanding loans below $30,000,000) will be subject to a prepayment premiu
Filing Documents
- aort-20250912.htm (8-K) — 31KB
- ex101.htm (EX-10.1) — 2196KB
- 0000784199-25-000145.txt ( ) — 2694KB
- aort-20250912.xsd (EX-101.SCH) — 2KB
- aort-20250912_lab.xml (EX-101.LAB) — 21KB
- aort-20250912_pre.xml (EX-101.PRE) — 12KB
- aort-20250912_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On September 12, 2025 (the "Second Amendment Effective Date"), Artivion, Inc. ("Artivion") entered into a Second Amendment to Credit and Guaranty Agreement (the "Amendment"), among Artivion, as borrower, certain subsidiaries of Artivion, as guarantors, the lenders party thereto and Ares Capital Corporation, as administrative agent, which amends the Credit and Guaranty Agreement dated as of January 18, 2024 (as amended from time to time prior to the date hereof, the "Credit Agreement"), among Artivion, as borrower, certain subsidiaries of Artivion, as guarantors, the lenders from time to time party thereto and Ares Capital Corporation, as administrative agent and collateral agent. The Amendment provides for (i) an extension of the maturity date of the existing term loans (the "Existing Term Loan Facility") and the existing revolving credit facility (the "Existing Revolving Credit Facility") under the Credit Agreement by one year to January 18, 2031, (ii) a reduction in the interest rate margin applicable to the Existing Term Loan Facility and the Existing Revolving Credit Facility and (iii) a new $150.0 million secured delayed draw term loan facility (the "New Delayed Draw Term Loan Facility" and, together with the Existing Term Loan Facility, the "Term Loan Facilities"). There are no scheduled repayments of principal required to be made prior to the final maturity date under the Credit Agreement. Artivion has the right to prepay loans under the Credit Agreement in whole or in part at any time, provided that any prepayment of loans under the Term Loan Facilities (or loans under the Revolving Credit Facility to the extent reducing the balance of outstanding loans below $30,000,000) will be subject to a prepayment premium of 1.00% if the prepayment occurs prior to July 18, 2027. On and after the Second Amendment Effective Date, (i) loans under the Term Loan Facilities bear interest, at Artivion's option, at
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 10.1 Second Amendment to Credit and Guaranty Agreement, dated as of September 12, 2025, by and among Artivion, Inc., as the borrower, On-X Life Technologies Holdings, Inc., On-X Life Technologies, Inc. and Ascyrus Medical, LLC, as subsidiary guarantors, the lenders from time to time party thereto and Ares Capital Corporation, as administrative agent. 104 Inline XBRL for the cover page of this Current Report on Form 8-K. -3-
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Artivion, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 15, 2025 ARTIVION, INC. By: /s/ Lance A. Berry Name: Lance A. Berry Title: Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer -4-